[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336905-105":59,"doc-detail-336905-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","goldi-complexes-based-on-nonsteroidal-anti-inflammatory-derivatives-as-multi-target-drugs-against-colon-cancer","Gold(I) Complexes Based on Nonsteroidal Anti-Inflammatory Derivatives as Multi-Target Drugs against Colon Cancer","","Targeting inflammation and the molecular drivers of inflammatory processes offers a viable route for cancer prevention and therapy. Anti-inflammatory strategies, including NSAIDs and metal-based agents, have therefore gained attention for interfering with multiple pathways that support tumor progression. This work presents new phosphane gold(I) complexes derived from nonsteroidal anti-inflammatory drugs as multitarget agents against colon cancer. Inhibitory effects in Caco2-/TC7 are linked to COX-1/2 inhibition, thioredoxin reductase (TrxR)-dependent reactive oxygen species modulation, and apoptosis induction.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/goldi-complexes-based-on-nonsteroidal-anti-inflammatory-derivatives-as-multi-target-drugs-against-colon-cancer/336905/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/goldi-complexes-based-on-nonsteroidal-anti-inflammatory-derivatives-as-multi-target-drugs-against-colon-cancer/336905.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are NSAID-based strategies considered promising for colon cancer?","Question",{"text":112,"@type":113},"NSAIDs can interfere with tumor-promoting inflammatory processes. Their anticancer effects involve disrupting the tumor microenvironment and promoting apoptosis, while also influencing chemosensitivity and migration.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What cellular mechanisms are proposed for the most active gold(I) complexes?",{"text":117,"@type":113},"The active complexes are linked to cyclooxygenase-1/2 inhibition, modulation of reactive oxygen species through targeting thioredoxin reductase (TrxR) activity, and induction of apoptosis in colon cancer cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the role of COX-1 and COX-2 in the context of colon cancer?",{"text":121,"@type":113},"COX-1 is generally expressed in many tissues and helps maintain physiological homeostasis, while COX-2 is triggered by inflammation and acts as a tumor promoter. COX-2 overexpression can therefore indicate cancer development and motivate COX-2 selective inhibition.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336905,1790602915,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","This article is licensed under CC-BY 4.0   \n[pubs.acs.org/IC](pubs.acs.org/IC)  Article   \nGold(I) Complexes Based on Nonsteroidal Anti-Inflammatory Derivatives as Multi-Target Drugs against Colon Cancer  \nJavier Saez, Javier Quero, María Jeśus Rodriguez-Yoldi, M. Concepción Gimeno, * and Elena Cerrada *  \n Cite This: Inorg. Chem. 2024, 63, 19769−19782  \nRead Online  \n\n|  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- |\n| ACCESS   | Metrics & More |  |  Article Recommendations |  | *sı Supporting Information |\n\nABSTRACT: Targeting inflammation and the molecules involved in the inflammatory process could be an effective cancer prevention and therapy strategy. Therefore, the use of anti-inflammatory strategies, such as NSAIDs and metalbased drugs, has become a promising approach for preventing and treating cancer by targeting multiple pathways involved in tumor progression. The present work describes new phosphane gold(I) complexes derived from nonsteroidal antiinflammatory drugs as multitarget drugs against colon cancer. The antiproliferative effect of the most active complexes, [Au(L3)(JohnPhos)] (3b), [Au(L4) -(CyJohnPhos)] (4a) and [Au(L4)(JohnPhos)] (4b) against colon cancer cells (Caco2-/TC7) seems to be mediated by the inhibition of the enzyme cyclooxygenase-1/2, modulation of reactive oxygen species levels by targeting thioredoxin reductase (TrxR) activity, and induction of apoptosis in cancer cells. Additionally, the three complexes exhibit high selectivity index values toward noncancerous cells. The research highlights the importance of maintaining cellular redox balance and the role of TrxR in cancer cell survival.  \n■ INTRODUCTION  \nColon cancer, also known as colorectal cancer, represents oneof the most common cancers diagnosed in older adults being one of the leading causes of cancer deaths worldwide.1 While surgical resection and chemotherapy remain the main curative options for colon cancer, adjuvant therapy continues to play an important role in preventing disease recurrence and metastasis. Several factors increase the risk of developing colon cancer, including an aging population and dietary habits of highincome countries, family history of colon cancer or polyps, personal history of inflammatory bowel disease (such as Crohn’s disease or ulcerative colitis), and certain genetic syndromes.2−4 Chronic intestinal inflammation has been associated with the development of colon cancer. Recent studies indicate that in genetically predisposed individuals, the innate immune system could promote colon tumor development in chronic inflammation, particularly in response to specific native microorganisms or cellular debris.5 Inflammation is also likely to be involved in other forms of colon cancer, both sporadic and hereditary.6 Additionally, chronic inflammation stimulates cell proliferation, angiogenesis, and metastasis, while simultaneously reducing the immune system response and the effectiveness of chemotherapeutic agents.7,8 As a result, targeting inflammation and the molecules involved in the inflammatory process could represent a good strategy for cancer prevention and therapy.9  \nMany anti-inflammatory compounds, including NSAIDs (nonsteroidal anti-inflammatory drugs), have been reported to exhibit anticancer activities. They can disrupt the tumor  \nmicroenvironment by diminishing cell migration while enhancing apoptosis and chemo-sensitivity.9−13 Specifically, for colorectal cancer, a great deal of epidemiological and preclinical studies endorse NSAIDs as a chemopreventive effect.14 Several clinical cancer trials to date have supported the chemopreventive and chemotherapeutic potential of NSAIDs alone or in combination with other drugs in colorectal cancer (NCT02052908, NCT01786200, NCT05411718, NCT01719926, NCT00473980, NCT00002796).15  \nThe main anticancer mechanism attributed to NSAIDs is the inhibition of cyclooxygenases (COX),16 leading to a reduction in prostaglandin production, which plays a crucial ","cbCaipEFoSvQZAcq","https://ap.wps.com/l/cbCaipEFoSvQZAcq","pdf",3524494,14,"English","# Introduction\n## Colon cancer burden and risk factors\n## Inflammation as a driver of colon cancer\n## NSAIDs and COX inhibition as anticancer mechanisms\n## COX-1/COX-2 roles and COX-2 as a marker\n## Medicinal inorganic chemistry and metal-based drugs","[{\"question\":\"Why are NSAID-based strategies considered promising for colon cancer?\",\"answer\":\"NSAIDs can interfere with tumor-promoting inflammatory processes. Their anticancer effects involve disrupting the tumor microenvironment and promoting apoptosis, while also influencing chemosensitivity and migration.\"},{\"question\":\"What cellular mechanisms are proposed for the most active gold(I) complexes?\",\"answer\":\"The active complexes are linked to cyclooxygenase-1/2 inhibition, modulation of reactive oxygen species through targeting thioredoxin reductase (TrxR) activity, and induction of apoptosis in colon cancer cells.\"},{\"question\":\"What is the role of COX-1 and COX-2 in the context of colon cancer?\",\"answer\":\"COX-1 is generally expressed in many tissues and helps maintain physiological homeostasis, while COX-2 is triggered by inflammation and acts as a tumor promoter. COX-2 overexpression can therefore indicate cancer development and motivate COX-2 selective inhibition.\"}]","Gold(I) Complexes Based on Nonsteroidal Anti-Inflammatory Derivatives as Multi-Target Drugs against Colon Cancer | PDF",1790017018,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/00ff84e04ba7a5b0664a00da8310dd05.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36452c67504b7fc50b0a474e640b1e16.webp",982,1295,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de8786acc7ce6ec55b2bf87214433aab.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c0468f92a388ea18a90b6511b913745.webp",980,1292]